SOPARFIN SCA SCA

About SOPARFIN SCA SCA

SOPARFIN SCA is above all a governance and control vehicle at the core of Vetoquinol SA’s shareholder structure. In the company’s ecosystem, the most notable role associated with this entity is that of the family representative and long-standing leader historically linked to it, namely Étienne Frechin, working alongside Demabel, the management company that acts as general partner and manages the holding structure. Soparfin SCA is the Frechin family’s top holding company and is the key controlling shareholder of Vetoquinol SA, making it central to the group’s capital stability and long-term strategic orientation. Vetoquinol’s reference documents state that the Frechin family controls the group through Soparfin SCA, and that Demabel serves as the holding’s managing company. Vetoquinol also reports that Soparfin SCA still held more than 63% of the company’s share capital in 2024, underlining its decisive influence over the listed issuer. Within this framework, the most emblematic professional trajectory associated with Soparfin SCA is that of Étienne Frechin, a founding figure in Vetoquinol’s development. Over time, he held several senior positions within the group, including production director, chief executive officer, chairman and chief executive officer, and later chairman of the board. This continuity reflects a long-term entrepreneurial governance model built on family succession, capital control, and a consistent strategic vision. In practice, Soparfin SCA has supported Vetoquinol’s international expansion while maintaining a governance architecture that includes specialized committees, independent directors, and the separation of the roles of chairman and chief executive officer introduced in 2010. Overall, the holding demonstrates strong expertise in capital control, listed-group oversight, and the governance of a family-owned animal health company with an international footprint.